Free Trial

NextCure (NXTC) Earnings Date, Estimates & Call Transcripts

NextCure logo
$4.90 -0.19 (-3.63%)
As of 08/8/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NextCure Earnings Summary

NextCure issued Q2 2025 earnings on August 7, 2025, reporting an EPS of -$11.29, which missed analysts' consensus estimates of -$4.62 by $6.67. With a trailing EPS of -$21.13, NextCure's earnings are expected to grow next year, from ($1.87) to ($1.44) per share.

Latest Q2
Earnings Date
Aug. 7Estimated
Consensus EPS
(Aug. 7)
-$4.62
Actual EPS
(Aug. 7)
-$11.29 Missed By -$6.67

Q2 2025 Earnings Resources

Get NextCure Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NextCure and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

NXTC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NextCure Analyst EPS Estimates

Current Year EPS Consensus Estimate
($1.87) EPS
Next Year EPS Consensus Estimate
($1.44) EPS

NextCure Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025-$4.62-$11.29 -$6.67-$11.29--
5/1/2025Q1 2025-$4.80-$4.68+$0.12-$0.39--
3/6/2025Q4 2024-$4.08-$4.92 -$0.84-$0.41--
11/7/2024--$4.20-$4.92 -$0.72-$0.41--
8/1/2024--$4.32-$6.60 -$2.28-$0.55--
5/2/2024Q1 2024-$5.40-$7.32 -$1.92-$0.61--
3/21/2024Q4 2023-$6.48-$6.24+$0.24-$0.52--
11/2/2023Q3 2023-$7.68-$6.12+$1.56-$0.51--

NextCure Earnings - Frequently Asked Questions

NextCure (NASDAQ:NXTC) last announced its quarterly earning data on Thursday, August 7, 2025. Learn more on NXTC's earnings history.

In the previous quarter, NextCure (NASDAQ:NXTC) missed the analysts' consensus estimate of ($4.62) by $6.67 with a reported earnings per share (EPS) of ($11.29). Learn more on analysts' earnings estimate vs. NXTC's actual earnings.

NextCure (NASDAQ:NXTC) has a recorded net income of -$55.65 million. NXTC has generated -$21.13 earnings per share over the last four quarters.

NextCure's earnings are expected to grow from ($1.87) per share to ($1.44) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:NXTC) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners